Publication | Open Access
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
54
Citations
28
References
2024
Year
Financial support for the registry from Biogen, Novartis and Roche.
| Year | Citations | |
|---|---|---|
Page 1
Page 1